Search for: "State v. James J. Brooks" Results 81 - 100 of 130
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jul 2021, 4:12 am by Michael Douglas
There were three consequences of this removal: first, Fortnite could not be downloaded to an Apple device; secondly, previously installed iOS versions of Fortnite could not be updated; and, thirdly, Apple device users could not play against players who had the latest version of Fortnite.[22] 4         The Proceedings On the same day as Apple removed Fortnite from the App Store, Epic commenced antitrust proceedings in the United States District Court… [read post]
14 May 2012, 8:24 am by Schachtman
Mass. 1997)(occupational epidemiology of benzene exposure and benzene does not inform health effects from vanishingly low exposure to benzene in bottled water) Whiting v. [read post]
22 Feb 2015, 4:04 pm by INFORRM
On 20 February 2015, the Court of Appeal (McCombe and Sharp LJJ and Mitting J) gave judgment in the case of Rufus v Elliott ([2015] EWCA Civ 121). [read post]
16 Jan 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: CAFC: In re Comiskey rehearing en banc falls two votes short; important dissent by Moore J (Hal Wegner) (Inventive Step) (Patently-O) (Washington State Patent Law Blog) (Peter Zura's 271 Patent Blog) (Law360) (Patent Prospector) District Court Delaware: Document shredding voids 12 Rambus patents: Rambus v Micron… [read post]
22 Sep 2021, 9:27 am by Joel R. Brandes
” Here, the court’s determination to deny defendant’s request for attorney’s fees was largely based on its assessment of defendant’s credibility at trial regarding the state of her own finances, her failure to fully account for large sums of money that she had received, and her failure to fully account for assets belonging to plaintiff that she purportedly used for his benefit during the period they were separated. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
5 Jun 2017, 1:39 pm by Jamie Baker
Camp’s article A History of Tax Regulation Prior to the Administrative Procedure Act was cited in the following article: Brian Boyd, State v. [read post]
4 Oct 2023, 7:54 am by Sasha Volokh
Jones, 520 U.S. 681, 712–13 (1997) (Breyer, J., dissenting))) (internal quotation marks omitted). [read post]
24 Dec 2023, 9:05 pm by The Regulatory Review
Kenkel, Cornell Brooks School of Public Policy; Lisa A. [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier Foundation),… [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]